Skip to main content

MoneyWorks4Me

Clarification sought from Lupin

25 May 2015 Evaluate

The Exchange has sought clarification from Lupin with respect to news article appearing on Financial Express on May 22, 2015 titled ‘Some drugs made by Lupin, DRL & Mylan lose EU approval.’

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1764.60
Dr. Reddys Labs. 1344.00
Cipla 1365.40
Lupin 1988.30
Zydus Lifesciences 1180.80
View more..